Feb 15–18, 2027 | Rimrock Banff, Emblems Collection, Banff, AB, Canada
Scientific Organizers:
Joy Yu Zuchero and Peter Tessier
-
Scientific Organizers: Joy Yu Zuchero and Peter Tessier
Joy Yu Zuchero, PhD
Denali Therapeutics Inc
Peter Tessier
University of Michigan
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Monday, February 15, 2027
Tuesday, February 16, 2027
The Neurovasculature in Health, Disease, and CNS Drug Delivery
in vitro Shuttle Trafficking
in vivo Trafficking using Live Imaging
TfR and CD98hc-Mediated vs. Traditional IgG Delivery
Next-Generation Shuttles for Improved CNS Delivery
Leveraging FcRn to Enhance Antibody Transport Across the BBB
Engineering AAVs
Wednesday, February 17, 2027
Focused Ultrasound Drug Delivery for Alzheimer's Disease
Intrathecal ASO Delivery
AAV Delivery, New RMT Target
mRNA/LNP Delivery to CNS/gamma Secretase Targeted BBB Crossing, Delivery of ASOs
Discovering Brain Shuttles and Targets through Multiplexed In Vivo Screening
Igf1R Binding GrabodyB Platform for Brain Delivery
BBB Glycocalyx in Drug Delivery
Thursday, February 18, 2027
Antibody Delivery
AAV Delivery of Zinc Finger Repressor for PrP
Learning the Rules of Engagement for Brain Delivery across Different Shuttles and Payload Modalities
In vivo Biofactories allow Multiple Routes to Reach the Brain for Lysosomal Diseases
Brain Shuttle, Trontinemab
Utilizing TfR to Deliver IDS for Treatment of Hunter Syndrome
Progress in CNS Therapeutic Development: Perspectives from a Neuroscientist and Investor
Friday, February 19, 2027
Subscribe for Updates